$ARNA Recent Headlines SP 500 back for another crack at

New Post Public Reply Private Reply Replies (0) Message Board

Mar 24, 2014 at 10:44 AM

$ARNA Recent Headlines

S&P 500 back for another crack at major support 12:21 p.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 12:41 p.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 1:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 2:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 2:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 7:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 10:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 10:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 7:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 7:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 8:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 1:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 12:07 p.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 8:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 8:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 1:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 2:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 4:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 3:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 10:32 a.m. July 30, 2012 - Val Brickates Kennedy

Direct To Consumer Television Advertising Marks The Tipping Point For Belviq Sales 9:34 a.m. Today - Seeking Alpha
March Madness: Final Four Investing Bracket 2014 6:36 p.m. March 20, 2014 - Seeking Alpha
Arena Down With Overall Market - Sales Data No Help 8:27 a.m. March 17, 2014 - Seeking Alpha
Interesting ARNA Put And Call Options For May 2nd 11:11 a.m. March 13, 2014 - TheStreet.com
Arena Sees Growth Continue With Belviq 4:01 p.m. March 7, 2014 - Seeking Alpha
Have Anti-Obesity Drug Companies Failed? 3:09 p.m. March 7, 2014 - Seeking Alpha
ARNA April 25th Options Begin Trading 11:09 a.m. March 6, 2014 - TheStreet.com
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data - Analyst Blog 10:58 a.m. March 5, 2014 - Zacks.com
Is A Short Squeeze Ahead for Arena Pharmaceuticals (ARNA)? - Tale of the Tape 9:23 a.m. March 4, 2014 - Zacks.com
10-K: ARENA PHARMACEUTICALS INC 4:52 p.m. March 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
Company news for March 03, 2014 - Corporate Summary 10:06 a.m. March 3, 2014 - Zacks.com
Future Sales Of Arena Pharmaceuticals' BELVIQ: Let's Make Some Informed, Quantitative Predictions Using Expected Value 8:01 a.m. March 3, 2014 - Seeking Alpha
Yellen Comments Help Lift Dow 1.4% on Week 2:03 a.m. March 1, 2014 - Barrons.com
Arena Prescription Sales Up: Stops Stock Slide 5:28 p.m. Feb. 28, 2014 - Seeking Alpha
Arena Posts Wider Loss, Misses Ests - Analyst Blog 12:20 p.m. Feb. 28, 2014 - Zacks.com
Benzinga's Top #PreMarket Losers 7:15 a.m. Feb. 28, 2014 - benzinga.com
Arena's Belviq Sales To Hit $150 Million In 2014? 12:10 a.m. Feb. 28, 2014 - Seeking Alpha
Arena Falls On Quarterly Results 7:42 p.m. Feb. 27, 2014 - Seeking Alpha
Arena Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript 7:25 p.m. Feb. 27, 2014 - Seeking Alpha
Arena -5.2% AH on Q4 miss, guidance 5:19 p.m. Feb. 27, 2014 - Seeking Alpha

Momentum Indicators for Health Care Equities -- Research on Arena Pharma, Hemispherx Biopharma, PDL BioPharma and Celgene 8:16 a.m. March 20, 2014 - PR Newswire - PRF
Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments - Analyst Notes on Arena, Horizon Pharma, Enanta, Vanda, and PTC 4:30 p.m. March 5, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2013 Financial Results 5:22 p.m. Feb. 27, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Provide Corporate Update and Report Financial Results on Thursday, February 27 9:00 a.m. Feb. 20, 2014 - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 11:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Announces Filing for Marketing Authorization of BELVIQ® (lorcaserin HCl) in Brazil 9:00 a.m. Feb. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences 9:00 a.m. Feb. 5, 2014 - PR Newswire - PRF
Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena 9:00 a.m. Jan. 9, 2014 - PR Newswire
Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference 9:00 a.m. Jan. 6, 2014 - PR Newswire
Collaborations, FDA Approvals, Appointments, Patents, and Stock Movements - Research Report on Aetna, United Therapeutics, Perrigo, Arena Pharmaceuticals, and Keryx Biopharmaceuticals 9:00 a.m. Dec. 31, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 11:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Insiders Trend Analysis: Tiger Oil and Energy Inc, Groupon Inc, General Motors Company Arena Pharmaceuticals 11:47 a.m. Dec. 19, 2013 - ACCESSWIRE
Opening Buzzers: General Motors Company, Sunedison Inc, Nokia Corporation, Arena Pharmaceuticals 11:11 a.m. Dec. 17, 2013 - ACCESSWIRE
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 9:00 a.m. Dec. 9, 2013 - PR Newswire
Bearish Stocks Analysis: Morgan Stanley, Microsoft Corporation, Arena Pharmaceuticals, Vale SA, JPMorgan Chase & Co 10:17 a.m. Dec. 6, 2013 - PR Newswire
Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners 10:45 a.m. Dec. 5, 2013 - ACCESSWIRE
Notable News Of The Day: BlackBerry Ltd, Arena Pharmaceuticals, Groupon Inc, Zynga Inc 10:56 a.m. Dec. 2, 2013 - ACCESSWIRE
Promising Partnerships, Stock Price Updates and Participation in Upcoming Healthcare Conferences - Research Report on Quest Diagnostics, Cigna, Arena, Theravance, and Volcano 9:00 a.m. Nov. 29, 2013 - PR Newswire
Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference 9:00 a.m. Nov. 27, 2013 - PR Newswire
Trend Analysis Scan: Synovus Financial, Arena Pharmaceuticals, Facebook Inc, J.C. Penney Company, Citigroup 9:49 a.m. Nov. 26, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stephanie Knepp Joins Exceptional Women Alliance

A New Chapter for a Seasoned Leader When a high flyer like Stephanie Knepp steps into a new arena, you know folks are going to sit up and pay attention. This time, she's making waves by joining the Exceptional Women Alliance (EWA), a heavy-hitting community of women leaders. With her extensive background in scaling businesses and empowering leaders, she's bound to bring...

Qfin Holdings Faces Securities Fraud Class Action Challenges

Troubles Mount for Qfin Holdings Well, you don't need a crystal ball to see this storm brewing for Qfin Holdings, Inc. (NASDAQ:QFIN). On the heels of a nasty 18.91% nosedive in their stock price, a class action lawsuit is looming overhead like a mischievous cloud ready to rain on investors' parades. It's the kind of legal and financial brew that could leave shareholders...

Direct Connection Unleashes Powerful HEMI V8 Engine Programs

HEMI V8 Legacy Reinvention at SEMA 2026 If you're the sort who gets their hands greasy restoring or revamping classic muscle, well, Direct Connection just made your life a whole lot easier. Stellantis' performance arm pulled the wraps off not just one, but six new HEMI V8 crate engine packages at the 2026 SEMA Show. Now, that's how you turn heads in Vegas. A New...

Lumentum Holders Question Marvell Deal Fairness: Legal Eyes

What's Brewing with Lumentum and Marvell? There's no denying the chatter on Wall Street when there's a potential shake-up, especially with a big merger at stake. We're staring down the barrel of an investigation concerning Lumentum Holdings Inc. (NASDAQ: LITE) and Marvell Technology, Inc.'s deal. The M&A Class Action Firm, helmed by Juan Monteverde, is the name leading...

PrimeBOT: Breaking Tech Molds with Celeb Backing

Not Your Average Tech Buzz It starts with Hollywood glitz and an unexpected dance partner. The PrimeBOT, a Chinese personal robot, is ditching the drab tech corner and seeping into mainstream culture. Imagine Johnny Depp slapping some paint on this machine alongside local kids. Now, picture the Kardashians casually dining with it, letting it join their lunchtime...

Synova Global Taps Eventus for Top Trade Surveillance

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Moberg Pharma Secures U.S. Patent for MOB-015 Innovation

Moberg Pharma's Fresh U.S. Patent: A Game Changer? Moberg Pharma just snagged a U.S. patent for their whiz-bang dosing of MOB-015. Yup, the FDA’s go-ahead is still out of reach, but this patent is like hitting a full house on the river—sweetening the pot significantly. It's all about onychomycosis, or nail fungus, if you're not up on your medical terms. With patent...

NJ Small Businesses: Free IT Security Checks Offered

Unpacking Corporate Technologies' Offer It's not every day a company doles out free consultations, but Corporate Technologies is doing just that. They're tossing New Jersey's small-to-mid businesses a lifeline with free IT and cybersecurity assessments. There's no catch, just thirty minutes of pure, no-nonsense evaluation of your tech setup. Couldn’t hurt to know where...

Wincomm & Portwell Unveil Medical AI Tech at MEDICA 2026

MEDICA 2026: Wincomm and Portwell Join Forces November's got one heck of an event lined up with MEDICA 2026, where Wincomm and Portwell are teaming up to showcase what they've got up their sleeves in medical AI computing. This whole shebang runs from November 16 to 19, with their setup in Hall 12, Stand C76, Düsseldorf, Germany. But why should investors care? Because...

Differentia Bio's AI: Transforming Drug Development Dynamics

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...